Medicus Pharma Ltd. - 8-K Filing

Medicus Pharma regains Nasdaq compliance after $4.25 million equity financing and $10.5 million debt exchange. (Items: 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, 8.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $MDCX

Read the full article at SEC EDGAR

More Regulatory news